Cellatope Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $5M

Cellatope General Information

Description

Developer of inflammatory diseases identification and monitoring solutions. The company helps user to analyze complement products bound to various blood cell types such as erythrocytes, platelets, reticulocytes, and lymphocytes.

Contact Information

Formerly Known As
StageMark
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 100 Technology Drive
  • Suite 400
  • Pittsburgh, PA 15219
  • United States
+1 (412)
Primary Industry
Diagnostic Equipment
Corporate Office
  • 100 Technology Drive
  • Suite 400
  • Pittsburgh, PA 15219
  • United States
+1 (412)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellatope Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Feb-2009 $5M Completed Generating Revenue
2. Early Stage VC (Series B) 02-Apr-2007 Completed Startup
1. Early Stage VC (Series A) 02-Oct-2005 $638K $638K Completed Startup
To view Cellatope’s complete valuation and funding history, request access »

Cellatope Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Cellatope’s complete cap table history, request access »

Cellatope Patents

Cellatope Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2009042423-A1 Methods and compositions for improved diagnostic assays Inactive 27-Sep-2007

Cellatope Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioAdvance Capital (Conshohocken) Venture Capital Minority
BlueTree Allied Angels Angel Group Minority
Innovation Works Venture Capital Minority
Meyer and Co. Merchant Banking Firm Minority
Pittsburgh Life Sciences Greenhouse Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Cellatope FAQs

  • When was Cellatope founded?

    Cellatope was founded in 2004.

  • Where is Cellatope headquartered?

    Cellatope is headquartered in Pittsburgh, PA.

  • What industry is Cellatope in?

    Cellatope’s primary industry is Diagnostic Equipment.

  • Is Cellatope a private or public company?

    Cellatope is a Private company.

  • What is the current valuation of Cellatope?

    The current valuation of Cellatope is .

  • What is Cellatope’s current revenue?

    The current revenue for Cellatope is .

  • How much funding has Cellatope raised over time?

    Cellatope has raised $2M.

  • Who are Cellatope’s investors?

    BioAdvance Capital (Conshohocken), BlueTree Allied Angels, Innovation Works, Meyer and Co., and Pittsburgh Life Sciences Greenhouse are 5 of 7 investors who have invested in Cellatope.

  • When was Cellatope acquired?

    Cellatope was acquired on 01-Feb-2009.

  • Who acquired Cellatope?

    Cellatope was acquired by Cypress Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process